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News focusPresident-elect Obama is wasting no time in setting out new federal science 
policies. Cyrus Martin reports.
Policy shake-upThe word ‘change’ was inextricably 
linked to the campaign of Barack 
Obama, and the burden of change 
(for the better) has been placed 
squarely on this man’s shoulders 
with a decisive victory in the recent 
US presidential election. Undeniably, 
the most pressing issue is the recent 
collapse of the economy, and Obama 
has laid out a plan incorporating both 
short-term economic stimuli, such 
as tax cuts to the middle class, as 
well as more long-term goals, such 
as investments in infrastructure. 
Interwoven with Obama’s economic 
policies is a comprehensive strategy 
to stimulate basic research and 
innovation. Obama argues that 
investment in science and technology 
will, among other benefits, keep 
America competitive in the global 
economy, alleviate dependence 
on foreign oil, avert damage to the 
environment, and provide for the 
health and welfare of American 
citizens. But what does an Obama 
presidency really mean for the future 
of science?
To appreciate the potential 
magnitude of the coming sea-change 
in science policy, it’s informative to 
look back at the last eight years. The 
National Institutes of Health — the 
engine driving basic research in  
the biomedical sciences — has seen 
its budget (in terms of purchasing 
power) slowly eroded over the past 
five years. This trend holds up for 
institutions that fund research in 
the physical sciences, such as the 
National Science Foundation, to which 
less and less money has flowed (as a 
percentage of US GDP) for decades. 
So, clearly, based on monetary 
support alone, science appears to 
have been woefully neglected of 
late. But, in addition, the current 
administration seems to have been 
dogged by the perception that it 
makes science policy decisions on 
ideological grounds, that it stocks 
key science positions in government 
with ‘yes’ men, and that it has gagged 
government scientists wishing to 
express views that conflict with those of the White House. David Hillis, an 
evolutionary biologist at the University 
of Texas, describes the climate aptly 
when he says, “We have been plagued 
by eight years of a war on science.”
Certainly, the allegations of 
censorship made by scientists such as 
Jim Hanson helped fuel the perception 
that the current administration has 
not always encouraged the flow of 
credible information. Hanson, who 
is the director of the NASA Goddard 
Institute for Space Studies and is also 
a longtime proponent of the view, 
held by most climate experts, that 
global warming is man made, claims 
the administration systematically 
subverted his input by preventing 
access to reporters and blocking 
press releases.
On the biomedical research front, 
there have been similar allegations 
that scientists have not been 
included on key policy decisions. A 
case in point is research on human 
embryonic stem cells, which, by 
executive order, has been deprived 
of federal funding except in the case 
of a limited number of cell lines. In 
2004, Elizabeth Blackburn, an eminent research scientist from the University 
of California, San Francisco, was 
dismissed from the Presidential 
Panel on Bioethics, a board 
charged with advising the president 
on a range of issues, including 
stem cells. Blackburn herself has 
expressed the view that the panel’s 
recommendations misrepresented the 
science of stem cells, and it has been 
widely reported that her dismissal 
constituted a deliberate effort by the 
administration to construct a panel 
that would ensure recommendations 
opposing stem-cell research. Similar 
charges were levied against the 
president concerning the rejection 
by the FDA of the contraceptive Plan 
B — a decision which two senators, 
including Hillary Clinton, claimed 
was motivated by politics rather than 
science. 
Do we have any reason to be 
optimistic for the future? There 
appears to be an overwhelming 
consensus among research scientists 
that an Obama presidency will mean 
both more money for research and 
policy decisions based on facts 
rather than political or ideological 
motivations. Mark Frye, a researcher 
in the Department of Physiological 
Sciences at UCLA, says, “I am Change: The byword of the Barack Obama presidential election campaign appears to be 
becoming a reality for many science policies. (Photo: Jeff Fusco/Getty Images.)
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The success of the election of 
Barack Obama and the speed with 
which he wants to change science 
policy is already having major effects 
overseas. By the end of the week of 
his election, one of the world’s largest 
energy companies, BP, announced it 
was pulling out of renewable energy 
schemes in the UK to focus its efforts 
on the US, which it now sees as its 
key market. The company follows 
Shell, which has also pulled out of 
renewable energy projects in the UK.
The decision is a big blow to Britain, 
which is keen to promote new wind 
power projects. And BP has advertised 
its green credentials widely in the UK 
and has a representative on the board 
of the British Wind Energy Association. 
But it believes the difficulty in getting 
planning permission for schemes 
and the lower economy of scale 
possible there made the sector far less 
attractive than the US. “The best place 
to get a strong rate of return for wind 
is in the US,” said a spokesman  
for BP. And Obama’s promise of  
$150 billion in renewable energy 
projects over the next 10 years to kick 
start a renewable energy revolution 
is likely to provide a wider surge in 
interest.
BP said about $1.5 billion would be 
spent next year on US wind projects 
and the company expected to spend 
$8 billion up to 2015.
In another area of early 
commitment, Obama has signalled 
his keenness to reverse federal 
opposition to embryonic stem-cell 
research which restricts funds to just 
a few historic cell lines. Researchers 
in Britain, however, where legislation 
has been developing to enhance 
opportunities for embryonic stem-
cell research, believe US moves are 
unlikely to have a great impact on 
their research. While they welcome 
the change in climate created by 
Obama’s preliminary statements, 
they believe that, unless there is a 
specific funding push in the states 
where embryonic stem-cell research 
is restricted, there is unlikely to be 
major impact internationally on the 
field.
But environmental groups around 
the world have widely welcomed 
the prospect of restrictions in the 
granting of oil-prospecting licences 
in environmentally sensitive areas, 
which Obama has also promised.
And delegates at this month’s 
climate change conference in 
Poland, which is a step towards 
developing a new international 
protocol to replace that signed 
in Kyoto, which the US did not 
ratify, are expecting a new era in 
negotiations that may, at last, see  
the US taking a major lead.
Barack Obama’s election is already 
having policy effects outside the 
country. Nigel Williams reports.
Rippling outextremely optimistic about the future. 
There are two general categories for 
my enthusiasm: the tangible benefits 
that will be brought by financially 
invigorated research programs, 
and perhaps the more important 
intangible benefits to morale, image 
and outlook that will be brought by 
replacing political ideologues with 
responsible scientists. Even if I myself 
never see a single dollar in increased 
research funding, I am elated and 
strongly motivated by simply knowing 
that the new administration takes 
an intelligent, scholarly and rigorous 
approach to science policy.” Echoing 
this sentiment, Joshua Dubnau, a 
behavioural geneticist at Cold Spring 
Harbor remarked, “In general, I am 
much more optimistic now than I 
was with the Bush administration 
or with McCain. I think Obama 
is smart, thoughtful, and has 
certainly given some well-meaning 
statements regarding the importance 
of research…unlike Bush/Cheney/
McCain, Obama appears to live 
in the reality-based universe.  So 
I do not think he will censor or 
subvert scientists when truths are 
inconvenient.” 
With regard to funding, Obama 
has certainly made some sweeping 
proposals. In specific terms, he 
plans to double the funding to both 
the National Institutes of Health and 
the National Science Foundation 
over the next 10 years and to pump 
150 billion dollars into clean-energy 
technologies. To stimulate research 
and development in the private 
sector, Obama promises to reinstate 
the R&D tax credit. In addition to 
direct infusions of cash into research, 
the fledgling administration would 
place an emphasis on education by 
distributing 20,000 stipends to K–12 
teachers in high-need areas and 
locations.
At the postgraduate level, the 
number of NSF fellowships would 
increase from 1,000 per year to 
3,000. Of course, these are all well-
intentioned goals, and not many would, 
in principle at least, oppose such a 
plan. But, is it feasible? While scientists 
seem hopeful, skepticism does exist 
concerning where the money will 
come from, especially considering the 
uncertain length of America’s tenure 
in Iraq. For example, Dubnau says, 
“I worry about whether or not the 
Obama administration will be willing to 
expend the political capital necessary to change priorities. How will they 
find resources to properly fund the 
infrastructure of this country (which 
includes science, education, bridges, 
roads, electrical grid, alternative 
energy, conservation, etc.) unless they 
are willing to make major changes to 
the areas of spending that compete 
with these goals?”
Position platforms aside, what 
about the man’s judgement? On the 
issue of climate change, it is clear 
that Obama’s views are in line with the 
scientific community in terms of the 
scope of the problem and the desire 
to re-engage international efforts to 
stem the crisis. But there are other 
hints that Obama is willing to listen, 
and base his policy decisions on, the 
advice of respected scientists that 
represent the consensus views of their 
fields. For one, he plans to elevate 
the presidential science advisor to a senior-level position with the title of 
Director of the Office of Science and 
Technology Policy.
In addition, Obama has promised to 
use a strict vetting process to appoint 
individuals to government bodies 
and advisory panels that is based on 
merit. Expressing her approval of this 
new climate, Elizabeth Blackburn, 
former member of the aforementioned 
Presidential Panel on Bioethics 
stated, “… I am thrilled to have an 
administration that recognizes the 
value of science and the importance 
of scientific input in the development 
of public policies.” If Obama’s 
rapid appointment of several key 
cabinet positions is any indication, 
we’ll soon see who he elevates to 
the top science positions in the US 
government and, as a result, gain 
some key insights into what the future 
holds for American science policy.
